269 related articles for article (PubMed ID: 6382569)
1. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
2. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.
Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966
[TBL] [Abstract][Full Text] [Related]
4. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
5. Expression of intermediate filaments in normal and neoplastic exocrine pancreas.
Santini D; Ceccarelli C; Martinelli GN; Pasquinelli G; Leone O; Marrano D; Mancini AM
Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653
[TBL] [Abstract][Full Text] [Related]
6. Absence of trypsinogen autoactivation and immunolocalization of pancreatic secretory trypsin inhibitor in acinar cells in vitro.
Arias AE; Böldicke T; Bendayan M
In Vitro Cell Dev Biol; 1993 Mar; 29A(3 Pt 1):221-7. PubMed ID: 8463187
[TBL] [Abstract][Full Text] [Related]
7. Secretin/cholecystokinin-stimulated secretion of trypsinogen and trypsin inhibitor in pure human pancreatic juice collected by endoscopic retrograde catheterization.
Eddeland A; Wehlin L
Hoppe Seylers Z Physiol Chem; 1978 Dec; 359(12):1653-8. PubMed ID: 738699
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
Paju A; Stenman UH
Crit Rev Clin Lab Sci; 2006; 43(2):103-42. PubMed ID: 16517420
[TBL] [Abstract][Full Text] [Related]
9. Production and some properties of monoclonal antibodies against human pancreatic secretory trypsin inhibitor.
Nagata K; Ide M; Yoshida N; Kono M; Kurobe M; Hayashi K
Biochem Int; 1990 Sep; 21(6):1065-72. PubMed ID: 1706918
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic secretory trypsin inhibitor immunoreactivity detected in serum-free culture medium of human pancreatic carcinoma cell line, CAPAN-1.
Ogata N; Murata A
Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):233-44. PubMed ID: 3358013
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic secretory trypsin inhibitor, cathodal trypsin, and pancreatic elastase in pancreatic juice collected at endoscopic retrograde cholangiopancreatography.
Marks WH; Ohlsson K; Wehlin L; Russick C
Curr Surg; 1985; 42(1):26-8. PubMed ID: 3844336
[No Abstract] [Full Text] [Related]
12. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in malignant pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M
Cancer Detect Prev; 2000; 24(6):572-8. PubMed ID: 11198271
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive pancreatic secretory trypsin inhibitor in gynecological diseases.
Murata A; Ogawa M; Matsuda K; Matsuura N; Kosaki G; Inoue M; Ueda G; Kurachi K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):493-9. PubMed ID: 6195699
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-molecular weight trypsin inhibitor, nafamostat mesilate, on trypsin activity using the pancreatic acinar cells.
Hashimoto D; Ohmuraya M; Wang J; Yamamura K; Hirota M; Baba H
Pancreas; 2009 Jul; 38(5):595-7. PubMed ID: 19550278
[No Abstract] [Full Text] [Related]
16. The bifunctional rat pancreatic secretory trypsin inhibitor/monitor peptide provides protection against premature activation of pancreatic juice.
Graf R; Klauser S; Fukuoka SI; Schiesser M; Bimmler D
Pancreatology; 2003; 3(3):195-206. PubMed ID: 12771515
[TBL] [Abstract][Full Text] [Related]
17. Trypsin inhibitors in bovine lung and pancreas during development.
Wilusz T; Wilimowska-Pelc A; Mejbaum-Katzenellenbogen W
Acta Biochim Pol; 1976; 23(2-3):269-75. PubMed ID: 9760
[TBL] [Abstract][Full Text] [Related]
18. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
J Mol Biol; 1987 Apr; 194(4):751-4. PubMed ID: 2443709
[TBL] [Abstract][Full Text] [Related]
19. Increased secretion of the pancreatic secretory trypsin inhibitor (PSTI-I, monitor peptide) during development of chronic pancreatitis in the WBN/Kob rat.
Graf R; Schiesser M; Bimmler D
Pancreatology; 2002; 2(2):108-15. PubMed ID: 12123090
[TBL] [Abstract][Full Text] [Related]
20. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
Hirota M; Ohmuraya M; Baba H
J Gastroenterol; 2006 Sep; 41(9):832-6. PubMed ID: 17048046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
